Email Updates

Search form

You are here


Media Coverage

  • It sounds like a pretty common-sense research practice, and yet, it’s still not very common. Transgender people continue to be excluded from HIV research, despite both trans men and trans women being at increased risk for HIV acquisition for a variety of structural reasons. In the HIV community, we’ve seen this play out recently, with transgender men (along with cisgender women) left out of the research studies and approval for emtricitabine/tenofovir alafenamide (Descovy), the second drug approved for pre-exposure prophylaxis (PrEP).

    January 24, 2020
    The BodyPro
  • The US Government knows how to do smart, effective HIV programming globally — but for the past three years, it has been getting in its own way. That’s because the US President’s Emergency Plan for AIDS Relief (PEPFAR), the largest government commitment to global HIV, was placed at risk when President Trump reintroduced the so-called global gag rule, applying it for the first time to PEPFAR.

    January 23, 2020
  • The two-year randomised control trial, which began in 2015, involved around 500 13 to 19-year-olds on antiretroviral treatment (ART) in rural Bindura and Shamva. Roughly half received standard of care adherence support from an adult counsellor, while the other half received standard support plus a combination of peer-led support through Zvandiri.

    January 23, 2020
  • Its most important finding is probably that, even if a PrEP programme results in a 75 percent rise in the likelihood of condomless anal sex in gay men, it would nonetheless lead to falls in gonorrhoea, due to more STI testing and treatment. The idea that PrEP might lead to a rise in sexually transmitted infections (STIs) in itself is not upheld, unless condom use falls almost to zero.

    January 23, 2020
  • Last week The World Health Organization (WHO) issued an official warning regarding the world’s supply of antibiotic medications, according to a report in The New York Times. WHO stated that the industrial pipeline for new antibiotic drugs is significantly slowing as profitability in this area decreases for drug companies.

    January 23, 2020
    HIV Plus Mag
  • Health officials from Eswatini (formerly Swaziland) are in Homa Bay County for benchmarking on eradication and management of HIV infections. The officials, from the country’s Health ministry, are learning new methods being used in the county governed by Mr. Cyprian Awiti.

    January 23, 2020
    Daily Nation
  • Most men with HIV know whether they have enough of the virus in their blood to make them contagious, but a new study suggests one in five may mistakenly think they can’t spread the virus even when they can.

    January 23, 2020
  • In more than 30 states, it is illegal for someone with HIV to have sex without first disclosing their status. Some are now pushing to change that, arguing that the laws are actually endangering public health.

    January 22, 2020
  • A single dose of the human papillomavirus (HPV) vaccine may provide as much protection as the currently recommended two or three doses, according to a new study. A simpler dosing schedule could potentially improve uptake, thereby reducing cancers caused by the virus.

    January 22, 2020
  • Here’s some great HIV news from across the pond: New HIV infections among gay and bisexual men in the United Kingdom dropped 71 percent since 2012, and the nation is on track to end HIV transmission by 2030, reports The United Kingdom consists of England, Scotland, Wales and Northern Ireland.

    January 21, 2020
  • Calling the US Air Force’s justifications for discharging military personnel living with HIV “outmoded and at odds with current science,” the US Court of Appeals for the Fourth Circuit last week upheld a lower court ruling in Roe and Voe v. Esper that allows two HIV-positive members of the Air Force, identified by pseudonyms Richard Roe and Victor Voe, to continue serving. The ruling also prevents, for now, the discharge of any other airmen based on their HIV status.

    January 16, 2020
    The Body
  • These results highlight the need to provide interventions to MSM living with HIV to support access to care and ensure current knowledge of viral load, and to continue to support primary prevention of HIV through condom use and pre-exposure prophylaxis (PrEP). For couples, particularly serodiscordant male couples, interventions that can teach the couple how to collaborate to achieve and maintain viral suppression for the positive partner are an urgent and pragmatic programmatic priority that can equip couples with the knowledge required to correctly implement U=U strategies.

    January 7, 2020

Published Research